U.S. Virology and Bacteriology: Sales and Volume Segment Forecasts for 100 Tests, Supplier Shares by Test, Innovative Technologies, Competitive Strategies, Emerging Opportunities

Publisher Name :
Date: 30-Sep-2016
No. of pages: 1037

Complete report $9,850.  DataPack  (test volumes, sales forecasts, supplier shares) $6,400.

VPGMarketResearch.com's new report is a strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key US market trends; reviews current and emerging assays; analyzes potential applications of innovative diagnostic technologies; forecasts volume and sales for over 100 infectious disease tests by assay, and market segment; provides test volume estimates by method (molecular, serology/immunodiagnostics, culture/microscopy); profiles leading players and potential market entrants; and suggests alternative business expansion strategies for suppliers.
 
Rationale

This comprehensive report will assist diagnostics industry executives, as well as companies planning to diversify into the dynamic and rapidly expanding microbiology testing market, in evaluating emerging opportunities and developing effective business strategies.
  
Microbiology testing is one of the most rapidly growing segments of the in vitro diagnostics industry, and the greatest challenge facing suppliers during this decade. Among the main driving forces is continuing spread of AIDS, which remains the world’s major health threat and a key factor contributing to the rise of opportunistic infections; threat of bioterrorism; advances in molecular diagnostic technologies; and a wider availability of immunosuppressive drugs.

Although for some infections the etiology is still a mystery, while for others the causative microorganisms are present in minute concentrations long before the occurrence of first clinical symptoms, recent advances in genetic engineering and detection technologies are creating exciting opportunities for highly sensitive, specific and cost-effective products.

Opportunities and Strategic Recommendations

- Emerging opportunities for new instrumentation,
  reagents kits, IT and other products with significant market
  appeal during the next five years.

- Design criteria for decentralized testing products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Infectious Diseases Analyzed in the Report

AIDS/HIV, Adenovirus, Aeromonads, Bartonella, Blastocystis Hominis, Campylobacter,
Candida, Chancroid, Chlamydia, Clostridium, Coronavirus, Coxsackievirus, Cryptosporidium,
Cyclospora, CMV, E. Coli, Echovirus, Encephalitis, Enterovirus, EBV, Giardia, Gonorrhea,
Granuloma Inguinale, Hantavirus, H. Pylori, Hepatitis, Herpes Influenza, Legionella, Lyme disease,
Lymphogranuloma, Malaria, Measles, Meningitis, Microsporidium, Mononucleosis, Mumps,
Mycoplasma, HPV, Parvovirus, Pneumonia, Polyomaviruses, Pseudomonas, Rabies, RSV, Rhinovirus, Rotavirus , Rubella, Salmonella, Septicemia, Shigella, Staphylococci, Streptococci, Syphilis, Toxoplasmosis, Trichomonas, TB, Vibrio, West Nile, Yersinia.

Market Segmentation Analysis

- Sales and market shares of major suppliers
  by individual test.

- Volume and sales forecasts for over 100 infectious disease
   assays by individual test and market segment:

     ° Hospitals
     ° Blood Banks
     ° Commercial/Private Laboratories
     ° Physician Offices/Group Practices
     ° Public Health Laboratories

- Test volume estimates by method (molecular, serology/immunodiagnostics,
   culture/microscopy).

- Review of the market dynamics, trends,
  structure, size, growth and major suppliers.

Current and Emerging Products

- In-depth examination of over 100 major diseases,
  including their etiology, current diagnostic tests,
  vaccines, drugs and market needs.

- Review of major analyzers used for infectious disease
  testing, including their operating
  characteristics, features and selling prices.

Technology Review

- Assessment of molecular diagnostic, monoclonal antibody,
  immunoassay, and other technologies and their potential
  applications for infectious disease testing.

- Global listings of companies developing or
  marketing infectious disease diagnostic products
  by individual test.

Competitive Assessments

- Strategic assessments of major suppliers and
  emerging market entrants, including their sales, product
  portfolios, marketing tactics, collaborative
  arrangements and new products in R&D.

Contains 1,037 pages and 177 tables

U.S. Virology and Bacteriology: Sales and Volume Segment Forecasts for 100 Tests, Supplier Shares by Test, Innovative Technologies, Competitive Strategies, Emerging Opportunities

Table of Contents

I. Introduction
II. Worldwide Market Overview
A. Business Environment
B. Market Structure
C. Market Size and Growth
III. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VI. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VII. Worldwide Overview of Major Tests, Technologies, and Instrumentation
A. Major Infectious Disease Tests
1. AIDS: HIV/HIV-1/2/Combo, HIVAg/HIV NAT, Western Blot, HTLV-I/II
2. Adenovirus 3. Aeromonas
4. Anthrax/Bacillus Anthracis
5. Arboviruses
6. Babesiosis
7. Bacillary Epithelioid Angiomatosis (BEA) and Other Bartonella (Rochalimaea)
8. Blastocystis Hominis
9. Brucella
10. Campylobacter 11. Candida 12. Chagas Disease
13. Chancroid 14. Chlamydia
15. Clostridium Difficile
16. Coronaviruses
17. Coxsackieviruses
18. Creutzfeldt-Jakob's Disease
19. Cryptosporidium Parvum
20. Cyclospora Cayetanensis
21. Cytomegalovirus
22. Ebola Virus
23. E. Coli
24. EchoVirus
25. Encephalitis
26. Enteroviruses
27. Epstein-Barr Virus
28. Giardia Lamblia
29. Gonorrhea
30. Granuloma Inguinale
31. Hantavirus
32. Helicobacter Pylori
33. Hepatitis: HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, ALT/SGPT
34. Herpes Simplex Virus
35. Human Herpes Virus-6 (HHV-6)
36. Influenza Viruses
37. Legionella
38. Lyme Disease
39. Lymphogranuloma Venereum (LGV)
40. Malaria
41. Measles (Rubeola)
42. Meningitis
43. Microsporidium
44. Mononucleosis
45. Mumps
46. Mycoplasma
47. Papillomaviruses
48. Parvovirus B19
49. Pneumonia
50. Polyomaviruses
51. Pseudomonas Aeruginosa
52. Rabies 53. Respiratory Syncytial Virus (RSV)
54. Rhinoviruses
55. Rotavirus
56. Rubella
57. Salmonellosis
58. Septicemia
59. Shigellosis
60. Staphylococcus Aureus
61. Streptococci
62. Syphilis
63. Toxoplasmosis
64. Trichomonas Vaginalis
65. Tuberculosis
66. Vibrio
67. West Nile Virus
68. Yersina
B. Instrumentation Review: Operating Characteristics, Features and Selling Princes of Leading Infectious Disease Automated and Semiautomated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
VIII. U.S.A. Infectious Disease Testing Market
A. Executive Summary
B. Business Environment
C. Market Structure
D. Market Size, Volume by Method, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test
IX. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher
- Wallac/PE
- Wako

List of Tables

Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Adenovirus Tests
Major Companies Developing or Marketing Bartonella Tests
Major Companies Developing or Marketing Campylobacter Tests
Major Companies Developing or Marketing Candida Tests
Major Companies Developing or Marketing Chlamydia Tests
Major Companies Developing or Marketing Clostridium Tests
Major Companies Developing or Marketing Coronavirus Tests
Major Companies Developing or Marketing Cryptosporidium Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Echovirus Tests
Major Companies Developing or Marketing Enterovirus Tests
Major Companies Developing or Marketing EBV Tests
Major Companies Developing or Marketing Giardia Tests
Major Companies Developing or Marketing Gonorrhea Tests
Major Companies Developing or Marketing Hantavirus Tests
Major Companies Developing or Marketing Helicobacter Pylori Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing Herpes Tests
Major Companies Developing or Marketing Influenza Tests
Major Companies Developing or Marketing Legionella Tests
Major Companies Developing or Marketing Lyme Disease Tests
Major Companies Developing or Marketing Lymphogranuloma Tests
Major Companies Developing or Marketing Malaria Tests
Major Companies Developing or Marketing Measles Tests
Major Companies Developing or Marketing Meningitis Tests
Major Companies Developing or Marketing Microsporidium Tests
Major Companies Developing or Marketing Mononucleosis Tests
Major Companies Developing or Marketing Mumps Tests
Major Companies Developing or Marketing Mycoplasma Tests
Major Companies Developing or Marketing Papilloma Virus Tests
Major Companies Developing or Marketing Parvovirus Tests
Major Companies Developing or Marketing Pneumonia Tests
Major Companies Developing or Marketing RSV Tests
Major Companies Developing or Marketing Rotavirus Tests
Major Companies Developing or Marketing Rubella Tests
Major Companies Developing or Marketing Salmonella Tests
Major Companies Developing or Marketing Septicemia Tests
Major Companies Developing or Marketing Shigella Tests
Major Companies Developing or Marketing Staphylococci Tests
Major Companies Developing or Marketing Streptococci Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Toxoplasmosis Tests
Major Companies Developing or Marketing Trichomonas Tests
Major Companies Developing or Marketing Tuberculosis Tests
Major Companies Developing or Marketing West Nile Tests
Major Companies Developing or Marketing Yersinia Tests
U.S.A. Summary Table All Infectious Diseases Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Laboratories Performing Infectious Disease Tests By Market Segment
U.S.A. Hospital Laboratories Performing Infectious Disease Tests by Bed Size
U.S.A. Commercial/Private Laboratories Performing Infectious Disease Tests by Annual Test Volume
U.S.A. Physician Office Laboratories Performing Infectious Disease Tests by Practice Size
U.S.A. All Market Segments Infectious Disease Test Volume Forecast
U.S.A. All Market Segments Infectious Disease Test Volume by Method
U.S.A. Hospital Laboratories Infectious Disease Test Volume Forecast
U.S.A. Blood Banks Infectious Disease Test Volume Forecast
U.S.A. Physician Office Laboratories Infectious Disease Test Volume Forecast
U.S.A. Commercial/Private Laboratories Infectious Disease Test Volume Forecast
U.S.A. Public Health Laboratories Infectious Disease Test Volume Forecast
U.S.A. All Market Segments Infectious Disease Diagnostics Market Forecast
U.S.A. Hospital Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Blood Banks Infectious Disease Diagnostics Market Forecast
U.S.A. Physician Office Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Commercial/Private Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. Public Health Laboratories Infectious Disease Diagnostics Market Forecast
U.S.A. HIV or HIV I/HIV II/Combo Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HIVAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Western Blot/Other Confirmatory Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Adenovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Aeromonads Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. BEA Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Blastocystis Hominis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Campylobacter Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Candida Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chancroid Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Chlamydia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Clostridium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Coronavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Coxsackievirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Cryptosporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Cyclospora Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. CMV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. E. Coli Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Echovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Encephalitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Enterovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. EBV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Giardia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Gonorrhea Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Granuloma Inguinale Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hantavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Helicobacter Pylori Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HAV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HbsAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HCV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HCV NAT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis C Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HBC Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HBS Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Anti-HAV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Hepatitis Delta Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBcAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HBeAg Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. ALT/SGPT Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Simplex I and II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Herpes Type VI Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. HTLV I or HTLV I/HTLV II Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Influenza Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Legionella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lyme Disease Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Lymphogranuloma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Malaria Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Measles Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Meningitis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Microsporidium Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mononucleosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mumps Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Mycoplasma Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Papilloma Virus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Parvovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Pneumonia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Polyomaviruses Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Pseudomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rabies Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. RSV Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rhinovirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rotavirus Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Rubella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Salmonella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Septicemia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Shigella Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Staphylococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Streptococci Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Syphilis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Toxoplasmosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Trichomonas Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Tuberculosis Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Vibrio Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. West Nile Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. Yersinia Test Volume and Diagnostics Sales Forecast by Market Segment
U.S.A. AIDS Testing Market Diagnostics Sales by Major Supplier
U.S.A. Adenovirus Testing Market Diagnostics Sales by Major Supplier
U.S.A. Campylobacter Testing Market Diagnostics Sales by Major Supplier
U.S.A. Candida Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chancroid Testing Market Diagnostics Sales by Major Supplier
U.S.A. Chlamydia Testing Market Diagnostics Sales by Major Supplier
U.S.A. CMV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Cryptosporidium Testing Market Diagnostics Sales By Major Supplier
U.S.A. Echovirus Testing Market Diagnostics Sales By Major Supplier
U.S.A. Enterovirus Testing Market Diagnostics Sales By Major Supplier
U.S.A. EBV Testing Market Diagnostics Sales by Major Supplier
U.S.A. Giardia Testing Market Diagnostics Sales by Major Supplier
U.S.A. Gonorrhea Testing Market Diagnostics Sales By Major Supplier
U.S.A. Helicobacter Pylori Testing Market Diagnostics Sales By Major Supplier
U.S.A. Hepatitis Testing Market Diagnostics Sales by Major Supplier
U.S.A. Hepatitis C Testing Market Diagnostics Sales By Major Supplier
U.S.A. Herpes Testing Market Diagnostics Sales By Major Supplier
U.S.A. Influenza Testing Market Diagnostics Sales By Major Supplier
U.S.A. Legionella Testing Market Diagnostics Sales By Major Supplier
U.S.A. Lyme Disease Testing Market Diagnostics Sales By Major Supplier
U.S.A. Measles Testing Market Diagnostics Sales By Major Supplier
U.S.A. Meningitis Testing Market Diagnostics Sales By Major Supplier
U.S.A. Mononucleosis Testing Market Diagnostics Sales By Major Supplier
U.S.A. Mumps Testing Market Diagnostics Sales By Major Supplier
U.S.A. Mycoplasma Testing Market Diagnostics Sales By Major Supplier
U.S.A. Pneumonia Testing Market Diagnostics Sales By Major Supplier
U.S.A. Rabies Testing Market Diagnostics Sales By Major Supplier
U.S.A. RSV Testing Market Diagnostics Sales By Major Supplier
U.S.A. Rotavirus Testing Market Diagnostics Sales By Major Supplier
U.S.A. Rubella Testing Market Diagnostics Sales By Major Supplier
U.S.A. Salmonella Testing Market Diagnostics Sales By Major Supplier
U.S.A. Septicemia Testing Market Diagnostics Sales By Major Supplier
U.S.A. Shigella Testing Market Diagnostics Sales by Major Supplier
U.S.A. Streptococci Testing Market Diagnostics Sales By Major Supplier
U.S.A. Syphilis Testing Market Diagnostics Sales By Major Supplier
U.S.A. Toxoplasmosis Testing Market Diagnostics Sales By Major Supplier
  • Global In-Vitro Diagnostics (IVD) Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 06-Dec-2016        Price: US 3480 Onwards        Pages: 111
    In-Vitro Diagnostics (IVD) is test that can detect diseases, conditions, or infections. Some tests are used in laboratory or other health professional settings and other tests are for consumers to use at home.Scope of the Report:This report focuses on the In-Vitro Diagnostics (IVD) in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and applic......
  • Europe Drug of Abuse Testing Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 111
    Notes: Sales, means the sales volume of Drug of Abuse Testing Revenue, means the sales value of Drug of Abuse Testing This report studies sales (consumption) of Drug of Abuse Testing in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Thermo Fisher Scientific - Siemens Medical Solutions......
  • Adenovirus 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 205
    The report presents a detailed analysis of the Adenovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Adenovirus definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices ......
  • Aeromonads 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 200
    The report presents a detailed analysis of the Aeromonads diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Aeromonads definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices ......
  • Campylobacter 2017-2021: Hospitals, Commercial Labs, Physician Offices, Public Health Labs--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 230
    The report presents a detailed analysis of the Campylobacter diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Campylobacter definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices......
  • Chancroid 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 220
    The report presents a detailed analysis of the Chancroid diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chancroid definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices  &......
  • Chlamydia 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 184
    The report presents a detailed analysis of the Chlamydia diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Chlamydia definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices  &......
  • Clostridium 2017-2021: Commercial Labs, Hospitals, Physician Offices, Public Health Labs--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 225
    The report presents a detailed analysis of the Clostridium diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Clostridium definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Physician Offices&nbs......
  • Cytomegalovirus (CMV) 2017-2021: US, Europe, Japan--Opportunities for Suppliers, Market Segment Forecasts and Shares, Competitive Strategies, Emerging Technologies, Instrumentation Review
    Published: 05-Dec-2016        Price: US 4350 Onwards        Pages: 231
    The report presents a detailed analysis of the Cytomegalovirus diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the CMV definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments:     - Hospitals     - Commercial/Private Labs     - Blood Banks    ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs